- U.S. Department of Defense: Agreements reached with Boeing and Raytheon. The agreements aim to enhance missile components production.
- U.S. Department of Defense: Agreement reached with Boeing and Raytheon to strengthen production of critical SM-3 Block IIA and SM-3 Block IB munitions.
- Spot platinum has just broken through the $1,740.00 per ounce mark, now trading at $1,740.05 per ounce, up 1.17% on the day; the main Nymex platinum futures contract is now quoted at $1,748.0 per ounce, up 0.91% on the day.
- Franco-Nevada announces Q3 2026 cash distribution of R$ 0.01 per unit, payable Sept. 30
- US Stock Market Preview | Major Index Futures Mixed; US July Retail Sales Data Coming Tonight; SanDisk (SNDK.US) Up Over 6% Pre-market
- Wall Street welcomes the "intervention bonus": Every time the Japanese government intervenes to rescue the market, it creates a perfect shorting window for yen bears.
- The U.S. Department of Defense has reached an agreement with Boeing and Raytheon.
- Spot gold has just broken through the $4,370.00 per ounce mark, now quoted at $4,370.67 per ounce, up 0.45% for the day; main COMEX gold futures are now quoted at $4,426.30 per ounce, up 0.13% for the day.
- Sparebanken Møre sets new bond interest rate at 5.38%
- Scienture Holdings 2Q Loss/Shr 7c >SCNX
- Medixall Group flags late filing of quarterly report for period ended June 30, 2026
- Certiplex delays Q2 10-Q filing, cites more time needed for compilation and review
- Lantheus wins FDA approval for TauklariFY Alzheimer’s tau PET imaging agent
- The surge in bulk commodities hides risks, AI’s aura fades—how long can this commodity bull market last?
- The yen retraces half of its intervention-driven gains on the weekly chart as the crucial 160 level approaches; a September rate hike may be the last line of defense.
- PMV Pharmaceuticals 2Q Research and Development Expenses $14.7M
- Zapata Quantum Q2 FY26 net loss widens to $1.84 million; revenue remains no revenue
- Aptevo names Mary Janatpour chief scientific officer
- S-Bank tender offer for Oma Savings Bank gets first supplement after H1 report
- Shore Capital sells Texas MedClinic to HCA Healthcare
- Trident Digital Tech JV projects Sikaflow revenue run-rate of about USD 65.5 million exiting 2026
- GT Biopharma 2Q Research and Development Expenses About $1.1M >GTBP
- Annovis Bio 2Q Loss/Shr 40c >ANVS
- Annovis Bio 2Q Loss $14.8M >ANVS
- Humana Assistans wins Swedish appeals court leave to challenge state damages ruling
- Clene Q2 FY26 net loss widens 81% to $13.42 million
- Quince Therapeutics: Runway to Fund Operations Through End 2028 >QNCX
- Standard Nuclear director Seth Michael Cohen files initial beneficial ownership statement
- 1847 Holdings Q2 FY26 net loss widens to $5.95 million; revenue falls 12.53% to $1.57 million
- Jæren Sparebank sets new bond interest rate at 5.13%
- Nuvera Q2 FY26 net loss narrows 62.09% to 160,770; revenue slips 0.8% to 17.66 million
- Quantum Cyber Q2 FY26 net loss widens to $11.02 million; operating loss widens to $9.89 million
- Eidesvik Offshore to present Q2 2026 results in digital briefing
- CCSC Technology International announces special meeting of Class A shareholders
- Genvor FY26 Q3 net loss widens 542.7% to $2.56 million
- PDS Biotech holds annual shareholder meeting, quorum reached
- Aptera Motors appoints Wellington J. Reiter as independent director, Audit Committee member
- Annovis Bio Q2 FY26 net loss widens to $14.82 million; R&D expenses more than doubled to $12.01 million
- GT Biopharma Q2 FY26 net loss narrows to $4.5 million; operating loss widens to $4.5 million
- VerifyMe 2Q Loss/Shr 4c >VRME
- Canary Gold reports visible gold grains in 29 of 30 RC samples at Madeira River project in Brazil
- Sphere 3D Q2 FY26 operating loss widens to USD 13.82 million; revenue rises 28% to USD 2.5 million vs Q1 FY26
- PMV Pharma Q2 FY26 net loss narrows 14.73% to $18.09 million
- Replimune FY27 Q1 net loss narrows to $69.8 million; R&D expenses fall to $49.3 million
- Tiger Gold names Sheryl Dhillon corporate secretary
- Quinsam Q2 FY26 net income swings to $0.4 million
- CMG launches modified Dutch auction share buyback offer up to C$20 million
- AE Fuels names Jason Tong CFO after Jack Cartmel resignation
- KAP forecasts FY26 HEPS up 82%-92% to 43.8-46.2 cents
- CSPi FY26 Q3 net loss widens to $846,000; sales fall 6.8% to $14.4 million
- Suncrete 2Q Loss/Shr 72c >RMIX
- Quince Therapeutics 2Q Loss/Shr $12.31 >QNCX
- Replimune Group: Tudriqev in Combination With Nivolumab Will Launch Within 60 Days >REPL
- Suncrete 2Q Rev $97.2M >RMIX
- Allarity Therapeutics 2Q Research and Development Expenses $1.3M >ALLR
- Ribbon Communications to attend Rosenblatt Tech Summit 2026 on AI theme
- Allarity Therapeutics Q2 FY26 net loss widens to $3.41 million; comprehensive loss narrows to $3.67 million
- Leatt Q2 FY26 net income drops 20% to USD 908,989; revenue rises 1% to USD 16.39 million
- Humana appeal against Swedish state lawsuit moves to appeals court after leave granted
- PAVmed Q2 FY26 GAAP net loss narrows to $5.48 million; revenue rises to $33,000
- Conifex Q2 FY26 net loss widens to $9.5 million; sales drop 32.2% to $23 million
- Foremost Clean Energy grants 68,000 stock options at $1.87 exercise price
- Innovative Eyewear CEO to present at Sidoti Micro-Cap Virtual Investor Conference
- VerifyMe Q2 FY26 net loss widens to $0.5 million; revenue drops 58% to $1.9 million
- SK Hynix’s performance surges in the first half of the year, with employee compensation and R&D investment soaring simultaneously
- Suncrete Q2 FY26 net loss widens to $37.1 million; revenue more than doubled to $97.2 million
- BRIEF-Conifex Q2 EBITDA CAD -6.3 Million
- BRIEF-PMV Pharmaceuticals Q2 EPS USD -0.34
- Computer Modelling Announces Commencement of Previously Announced Substantial Issuer Bid >CMG.T
- BRIEF-VerifyMe Q2 Adjusted EBITDA USD 0
- Allarity Therapeutics 2Q Loss/Shr 21c >ALLR
- AB KN Energies names Guy Mason audit committee chair
- IES Holdings to present at Midwest IDEAS Investor Conference, host 1x1 meetings
- Wells Fargo declares quarterly USD 18.75 dividend on Series L preferred stock
- Quince Q2 FY26 net loss widens to $75.5 million
- Evolv adds 70 customers in Q2 2026, strongest quarterly gain in two years
- Swiss Franc: Strong growth may curb losses against Euro – Rabobank
- Conifex Timber 2Q Rev $23M >CFF.T
- PMV Pharmaceuticals 2Q Loss/Shr 34c >PMVP
- PMV Pharmaceuticals 2Q Loss $18.1M >PMVP
- Replimune Group 1Q Loss/Shr 72c >REPL
- Replimune Group 1Q Loss $69.8M >REPL
- Galectin Therapeutics 2Q Loss/Shr 14c >GALT
- Galectin Therapeutics 2Q Research and Development Expenses $2.1M >GALT
- Montega raises Fabasoft price target to EUR 27, reiterates buy rating
- Venice Token is Predicted to Drop to $ 9.43 By Aug 18, 2026
- FGI INDUSTRIES LTD <FGI.O>: BENCHMARK RAISES TARGET PRICE TO $13 FROM $8
- First Carolina FY26 Q2 net income rises 10.87% to $5.1 million
- Amundi Physical Metals issues 9,000 Amundi Physical Gold ETC securities in Tranche 897
- RedotPay delays US IPO plans amid regulatory hurdles
- JinkoSolar schedules Q2 results release, earnings call
- TIDEWATER RENEWABLES LTD <LCFS.TO>: RBC RAISES TO OUTPERFORM FROM SECTOR PERFORM; RAISES TARGET PRICE TO C$25 FROM C$12.5
- LanzaTech Q2 FY26 net income swings to profit of $184.3 million; revenue slips 1% to $9 million
- Galectin Therapeutics Q2 FY26 net loss widens 21.17% to $9.11 million
- HANSAINVEST lifts q.beyond stake to 3.44% voting rights
- Prosafe updates financial calendar ahead of Q2, first-half 2026 results webcast
- Swiss Franc edges up from lows against the US Dollar with US Retail Sales on tap
- BIRD CONSTRUCTION INC. <BDT.TO>: ATB CORMARK CAPITAL MARKETS RAISES TARGET PRICE TO C$87 FROM C$57
- Correct: LanzaTech Global Sees 2026 Adjusted Ebitda Negative $22M-$26M >LNZA
- LanzaTech Global 2026 Adjusted Ebitda Negative $22M-$26M >LNZA
